
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark’s stock outlook remains positive due to its strong brand portfolio, which includes well-known names such as Huggies, Kleenex, and Depend, and a diversified revenue stream with over half of sales generated in North America and significant contributions from European, Asian, and Latin American markets. The company reported a 3.0% retail sales growth in January, albeit likely influenced by pantry loading, and has maintained consistent performance in early 2026 with a modest 0.1% growth in U.S. retail sales. Additionally, Kimberly-Clark's commitment to innovation and the strategic acquisition of Kenvue's consumer health portfolio are expected to enhance growth, with cost synergies anticipated from this acquisition, contributing positively by 2028.
Bears say
Kimberly-Clark has reported a decline in retail sales, with a -2.8% decrease in February and an average of +0.1% growth for the first quarter of 2026 to date. The company has revised its organic sales decline estimate for the third quarter of 2025 in North America from a previous +4.5% to -4.0%, indicating a significant downturn in performance. Additionally, earnings per share projections have been lowered for fiscal year 2025 from $7.60 to $7.41 and for 2026 from $8.00 to $7.85, reflecting deteriorating financial forecasts.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares